Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Hemasphere|March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health surveyClaire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
Clinical Cardiology|March 16, 2018
Rationale, design, and preliminary results of the Quebec Warfarin Cohort StudySylvie Perreault, Payman Shahabi, Robert Côté, et al.
British Journal of Haematology|July 1, 2021
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patientsPhilippe Rousselot, Luigina Mollica, Joëlle Guilhot, et al.
Transplantation and Cellular Therapy|October 6, 2020
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe InfectionsMaude Dumont-Lagacé, Qi Li, Mégane Tanguay, et al.
American Journal of Hematology|August 30, 2023
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO studyGiovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, et al.
The Lancet. Haematology|November 10, 2019
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility studySandra Cohen, Jean Roy, Silvy Lachance, et al.
Open Forum Infectious Diseases|January 30, 2026
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative DisordersLorne Schweitzer, Stéphanie Thiant, Cynthia Thérien, et al.
Blood|June 17, 2022
A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventionsTae-Hoon Shin, Yifan Zhou, Shirley Chen, et al.
The Lancet. Haematology|December 22, 2023
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 studyGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
Nature|May 18, 2018
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient hostMarlies Meisel, Reinhard Hinterleitner, Alain Pacis, et al.
Pageof 8